---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-039261"
form_type: "8-K"
ticker: "ESLA"
cik: "0001844417"
company_name: "Estrella Immunopharma, Inc."
filed_at: "2025-05-02T23:59:59+00:00"
generated_at: "2026-05-22T23:05:42.828833+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Estrella Immunopharma receives Nasdaq bid price deficiency notice; faces potential delisting

## Summary
- Nasdaq notified Estrella that common stock failed to maintain $1.00 minimum bid for 30 consecutive days through April 28, 2025.
- Company has 180-day compliance period (until October 27, 2025) to regain compliance with Bid Price Rule.
- If not compliant by October 27, may seek additional 180-day period if it meets other listing standards.
- No immediate effect on listing; common stock and warrants continue trading on Nasdaq under ESLA and ESLAW.

## SEC filing metadata
- accession: 0001213900-25-039261
- form_type: 8-K
- ticker: ESLA
- cik: 0001844417
- company_name: Estrella Immunopharma, Inc.
- filed_at: 2025-05-02T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844417/000121390025039261/0001213900-25-039261-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844417/000121390025039261/ea0240454-8k_estrella.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-039261
- JSON: https://secwatch.observer/filing/0001213900-25-039261.json
- Plain text: https://secwatch.observer/filing/0001213900-25-039261.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.